Evidence mapPaperPMID 42459721Full record

ArticleRSC advances2026

RP-HPLC quantification and separation of isomeric bacosides and exploration of their anti-schizophrenic potential by network pharmacology.

Hruta Sundar Swain, Balaram Ghosh, Onkar P Kulkarni, Vidya Rajesh

Abstract read
In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hruta Sundar SwainDepartment of Pharmacy, Birla Institute of Technology and Science Pilani-Hyderabad Campus Jawahar Nagar, Kapra Mandal Medchal District Telangana 500078 India.
Balaram GhoshDepartment of Pharmacy, Birla Institute of Technology and Science Pilani-Hyderabad Campus Jawahar Nagar, Kapra Mandal Medchal District Telangana 500078 India.ORCID https://orcid.org/0000-0002-3425-2439
Onkar P KulkarniDepartment of Pharmacy, Birla Institute of Technology and Science Pilani-Hyderabad Campus Jawahar Nagar, Kapra Mandal Medchal District Telangana 500078 India.
Vidya RajeshDepartment of Biological Sciences, Birla Institute of Technology and Science Pilani-Hyderabad Campus Jawahar Nagar, Kapra Mandal Medchal District Telangana 500078 India vidya@hyderabad.bits-pilani.ac.in.ORCID https://orcid.org/0000-0002-5024-0462

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia is a chronic and heterogeneous neuropsychiatric disorder involving positive, negative, and cognitive symptoms. Antipsychotic drugs prescribed currently are effective in controlling positive symptoms but offer limited benefits for negative and cognitive impairments as they focus on single-target or narrow-mechanism treatment strategies without sufficiently addressing the multi-factorial dysfunction underlying schizophrenia. Therefore, multi-target natural compounds like

Identifiers

PMID42459721
PMCPMC13370909

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.